Compounds > lamivudine
Page last updated: 2024-08-24

lamivudine and Diffuse Mixed Small and Large Cell Lymphoma

lamivudine has been researched along with Diffuse Mixed Small and Large Cell Lymphoma in 38 studies

Research

Studies (38)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (7.89)18.2507
2000's32 (84.21)29.6817
2010's3 (7.89)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baldini, L; Corradini, P; Facchetti, F; Farina, L; Goldaniga, M; Grossi, G; Labanca, S; Lampertico, P; Loglio, A; Lunghi, G; Pompa, A; Rumi, M; Viganò, M1
De Renzo, A; La Mura, V; Masarone, M; Pane, F; Perna, F; Persico, M; Romano, M; Rosato, V; Sasso, FC; Signoriello, G1
Arcaini, L; Gotti, M; Merli, M; Rattotti, S1
Cai, Q; Gao, Y; Huang, H; Lin, T; Lin, X; Liu, Y; Peng, R1
Asaka, M; Imamura, M; Masauzi, N; Tanaka, J; Tsutsumi, Y; Yamamoto, Y1
Ohmoto, K; Tsuduki, M; Yamamoto, S1
Ahmed, A; Ahmed, AM; Garcia, G; Keeffe, EB; Nguyen, MH; Simpson, ND; Simpson, PW1
Disel, U; Paydas, S; Sahin, B; Yavuz, S1
Asaka, M; Imamura, M; Kanamori, H; Kawamura, T; Masauzi, N; Miura, T; Obara, S; Tanaka, J; Tsutsumi, Y1
Ciancia, R; De Divitiis, B; De Renzo, A; Del Giudice, A; Pane, F; Persico, M; Picardi, M; Quintarelli, C; Rotoli, B; Salvatore, F1
Kang, YK; Kim, E; Kim, SB; Kim, SW; Kim, WK; Lee, GW; Lee, JH; Lee, JL; Lee, JS; Lee, KH; Oh, S; Ryu, MH; Suh, C1
Bilici, A; Ozguroglu, M; Serdengecti, S; Turna, H1
Asaka, M; Imamura, M; Kanamori, H; Kawamura, T; Masauzi, N; Miura, T; Obara, S; Saitoh, S; Tanaka, J; Tsutsumi, Y; Yamada, M1
Enomoto, M; Hino, M; Nishiguchi, S; Seki, S; Yamane, T1
Chen, PM; Chiou, TJ; Hsiao, LT; Lee, MY; Lin, PC; Poh, SB1
Asaka, M; Imamura, M; Kanamori, H; Masauzi, N; Mori, A; Tanaka, J; Tsutsumi, Y1
Guan, ZZ; He, YF; He, YJ; Huang, HQ; Jiang, WQ; Li, YH; Lin, TY; Lin, XB; Sun, XF; Wang, FH; Xia, ZJ; Zhang, L1
Planas, R; Ribera, JM; Sancho, JM; Vives, S1
Cheong, JW; Hahn, JS; Kim, JS; Kim, Y; Lee, CK; Lee, ST; Min, YH; Park, IH; Park, SY1
Bendenoun, M; Mazeron, MC; Sanson-le Pors, MJ; Schnepf, N; Sellier, P; Zini, JM1
Fei, G; Lee, LH; Lim, LC; Lim, ST; Loong, S; Quek, R; Tao, M; Yap, SP1
Chang, MC; Chao, TY; Chen, PJ; Cheng, AL; Hsiao, HH; Hsiung, CA; Hsu, C; Hwang, WS; Li, CC; Liao, YM; Lin, SF; Lin, TH; Liu, TW; Su, IJ; Tien, HF; Wang, MC; Wu, HB; Young, JH1
Chambers, S; Chapman, BA; Clark, FL; Drummond, MW; Patton, WN1
Al-Taie, OH; Gassel, AM; Mörk, H; Scheurlen, M; Weissbrich, B; Wilhelm, M1
Baccarani, M; Damiani, D; Ermacora, A; Fanin, R; Patriarca, F; Silvestri, F; Sperotto, A; Zaja, F1
Allegra, CJ; Hamilton, JM; Little, RF; Saif, MW; Wilson, WH1
Ambinder, R; Flexner, C; Grochow, L; Hamzeh, F; Harrington, W; Herndier, B; Kaplan, L; Lee, J; Levine, A; Ratner, L; Redden, D; Scadden, D; Straus, D; Tan, B; Tang, S1
Endo, T; Fujimoto, K; Haseyama, Y; Koike, T; Koizumi, K; Nishio, M; Sakai, T; Sawada, K; Takashima, H; Yamamoto, S1
Fujii, N; Harada, M; Kiura, K; Matsuo, K; Shimomura, H; Shinagawa, K; Takenaka, K1
Mascolini, M1
Hata, M; Ikegaya, S; Imamura, S; Kawahito, M; Kawai, Y; Tsutani, H; Ueda, T; Yoshida, A1
Motta, M; Pelizzari, A; Puoti, M; Rossi, G1
Hamaki, T; Kami, M; Kusumi, E; Miyakoshi, S; Morinaga, S; Mutou, Y; Ueyama, J1
De Marino, F; De Renzo, A; Morante, A; Persico, M; Rotoli, B; Russo, GD; Torella, R1
Andriani, A; Barlattani, A; Bibas, M; Stroffolini, T1
Eng, HL; Lee, CM; Liao, CA; Lu, SN; Wang, MC; Wu, HC1
Nakagawa, M; Sato, B; Simizu, Y; Suemura, M1
de Man, RA; Doorduijn, JK; Janssen, HL; Niesters, HG; Schalm, SW; van der Eijk, AA1

Reviews

6 review(s) available for lamivudine and Diffuse Mixed Small and Large Cell Lymphoma

ArticleYear
Antiviral therapies for managing viral hepatitis in lymphoma patients.
    Expert opinion on pharmacotherapy, 2017, Volume: 18, Issue:4

    Topics: Antiviral Agents; Guanine; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Surface Antigens; Hepatitis C; Humans; Lamivudine; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Rituximab; Tenofovir; Virus Activation

2017
Prevention of hepatitis B virus reactivation under rituximab therapy.
    Immunotherapy, 2009, Volume: 1, Issue:6

    Topics: Animals; Antibodies, Monoclonal, Murine-Derived; Arthritis, Rheumatoid; Hepatitis; Hepatitis B Antibodies; Hepatitis B virus; Humans; Immunosuppression Therapy; Lamivudine; Lymphoma, Non-Hodgkin; Purpura, Thrombocytopenic, Idiopathic; Rituximab; Virus Activation; Virus Replication

2009
Reactivation of hepatitis B virus with rituximab.
    Expert opinion on drug safety, 2005, Volume: 4, Issue:3

    Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antibodies, Viral; Antineoplastic Agents; Antiviral Agents; Autoimmune Diseases; Hepatitis B; Hepatitis B virus; Humans; Kinetics; Lamivudine; Lymphoma, Non-Hodgkin; Rituximab

2005
Prevention of hepatitis B flare-up during chemotherapy using lamivudine: case report and review of the literature.
    Annals of hematology, 1999, Volume: 78, Issue:5

    Topics: Female; Hepatitis B; Humans; Lamivudine; Lymphoma, Non-Hodgkin; Middle Aged; Reverse Transcriptase Inhibitors

1999
Reactivation of chronic hepatitis B infection following intensive chemotherapy and successful treatment with lamivudine: a case report and review of the literature.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2001, Volume: 12, Issue:1

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Female; Hepatitis B, Chronic; Humans; Immunocompromised Host; Lamivudine; Liver; Lymphoma, Non-Hodgkin; Male; Middle Aged; Recurrence; Reverse Transcriptase Inhibitors; Treatment Outcome

2001
Successful lamivudine therapy for post-chemotherapeutic fulminant hepatitis B in a hepatitis B virus carrier with non-Hodgkin's lymphoma: case report and review of the literature.
    Annals of hematology, 2001, Volume: 80, Issue:8

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carrier State; Cyclophosphamide; Doxorubicin; Hepatitis B; Humans; Lamivudine; Lymphoma, Non-Hodgkin; Male; Middle Aged; Reverse Transcriptase Inhibitors

2001

Trials

4 trial(s) available for lamivudine and Diffuse Mixed Small and Large Cell Lymphoma

ArticleYear
Lamivudine for the prevention of hepatitis B virus reactivation after high-dose chemotherapy and autologous hematopoietic stem cell transplantation for patients with advanced or relapsed non-Hodgkin's lymphoma single institution experience.
    Expert opinion on pharmacotherapy, 2009, Volume: 10, Issue:15

    Topics: Adult; Antineoplastic Agents; Combined Modality Therapy; Female; Hematopoietic Stem Cell Transplantation; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; Humans; Incidence; Lamivudine; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prospective Studies; Reverse Transcriptase Inhibitors; Severity of Illness Index; Transplantation, Autologous; Young Adult

2009
Lamivudine prophylaxis reduces the incidence and severity of hepatitis in hepatitis B virus carriers who receive chemotherapy for lymphoma.
    Cancer, 2006, Mar-15, Volume: 106, Issue:6

    Topics: Administration, Oral; Adolescent; Adult; Aged; Anthracyclines; Anti-HIV Agents; Antineoplastic Combined Chemotherapy Protocols; Child; Dose-Response Relationship, Drug; Female; Hepatitis B; Hepatitis B virus; Hodgkin Disease; Humans; Incidence; Lamivudine; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Primary Prevention; Prognosis; Survival Rate; Treatment Outcome

2006
A revisit of prophylactic lamivudine for chemotherapy-associated hepatitis B reactivation in non-Hodgkin's lymphoma: a randomized trial.
    Hepatology (Baltimore, Md.), 2008, Volume: 47, Issue:3

    Topics: Adult; Aged; Antiviral Agents; Female; Hepatitis B; Humans; Lamivudine; Lymphoma, Non-Hodgkin; Male; Middle Aged; Secondary Prevention; Survival Analysis; Treatment Outcome

2008
Chemotherapy for human immunodeficiency virus-associated non-Hodgkin's lymphoma in combination with highly active antiretroviral therapy.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2001, Apr-15, Volume: 19, Issue:8

    Topics: Adult; Anti-HIV Agents; Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Active; Combined Modality Therapy; Cyclophosphamide; Dose-Response Relationship, Drug; Doxorubicin; Female; Granulocyte Colony-Stimulating Factor; HIV Infections; Humans; Indinavir; Lamivudine; Lymphoma, AIDS-Related; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neutropenia; Prednisone; Stavudine; Treatment Outcome; Vincristine; Viral Load

2001

Other Studies

28 other study(ies) available for lamivudine and Diffuse Mixed Small and Large Cell Lymphoma

ArticleYear
Lamivudine prophylaxis prevents hepatitis B virus reactivation in anti-HBc positive patients under rituximab for non-Hodgkin lymphoma.
    Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2019, Volume: 51, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; DNA, Viral; Drug Therapy, Combination; Female; Hepatitis B; Hepatitis B Core Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Immunosuppressive Agents; Italy; Lamivudine; Lymphoma, Non-Hodgkin; Male; Middle Aged; Rituximab; Treatment Outcome; Virus Activation

2019
Management of the HBV reactivation in isolated HBcAb positive patients affected with Non Hodgkin Lymphoma.
    BMC gastroenterology, 2014, Feb-17, Volume: 14

    Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Cost-Benefit Analysis; Cyclophosphamide; DNA, Viral; Doxorubicin; Female; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Core Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Lamivudine; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Retrospective Studies; Rituximab; Vincristine; Virus Activation

2014
Combined lamivudine and interferon-alpha therapy for chemotherapy-induced reactivation of hepatitis B virus.
    The American journal of gastroenterology, 2003, Volume: 98, Issue:5

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Hepatitis B; Hepatitis B virus; Humans; Interferon-alpha; Lamivudine; Lymphoma, Non-Hodgkin; Male; Prednisone; Reverse Transcriptase Inhibitors; Vincristine; Virus Activation

2003
Prophylaxis against chemotherapy-induced reactivation of hepatitis B virus infection with Lamivudine.
    Journal of clinical gastroenterology, 2003, Volume: 37, Issue:1

    Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Reverse Transcriptase Inhibitors; Vincristine; Virus Activation

2003
Hepatitis B virus reactivation during fludarabine therapy in non-Hodgkin's lymphoma.
    Leukemia & lymphoma, 2003, Volume: 44, Issue:7

    Topics: Antineoplastic Agents; DNA (Cytosine-5-)-Methyltransferases; DNA, Viral; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Lymphoma, Non-Hodgkin; Male; Middle Aged; Remission Induction; Vidarabine; Virus Activation

2003
Possible efficacy of lamivudine treatment to prevent hepatitis B virus reactivation due to rituximab therapy in a patient with non-Hodgkin's lymphoma.
    Annals of hematology, 2004, Volume: 83, Issue:1

    Topics: Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Female; Hepatitis B Antibodies; Hepatitis B virus; Humans; Lamivudine; Lymphoma, Non-Hodgkin; Male; Middle Aged; Reverse Transcriptase Inhibitors; Rituximab; Treatment Outcome; Virus Activation

2004
Hepatitis B virus reactivation after fludarabine-based regimens for indolent non-Hodgkin's lymphomas: high prevalence of acquired viral genomic mutations.
    Haematologica, 2003, Volume: 88, Issue:11

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Carrier State; Drug Resistance, Viral; Female; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Antigens; Hepatitis B virus; Hepatitis C Antibodies; Humans; Lamivudine; Liver Failure; Lymphoma, Non-Hodgkin; Male; Middle Aged; Sequence Homology; Vidarabine; Virus Activation

2003
The prophylactic use of lamivudine can maintain dose-intensity of adriamycin in hepatitis-B surface antigen (HBs Ag)-positive patients with Non-Hodgkin's lymphoma who receive cytotoxic chemotherapy.
    Journal of Korean medical science, 2003, Volume: 18, Issue:6

    Topics: Adult; Aged; Antibiotics, Antineoplastic; Doxorubicin; Female; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Lamivudine; Lymphoma, Non-Hodgkin; Male; Middle Aged; Reverse Transcriptase Inhibitors; Survival Rate; Virus Activation

2003
Reactivation of hepatitis B virus infection with cytotoxic therapy in non-Hodgkin's lymphoma.
    Medical oncology (Northwood, London, England), 2004, Volume: 21, Issue:1

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alanine Transaminase; Alkaline Phosphatase; Anti-HIV Agents; Antineoplastic Agents; Female; gamma-Glutamyltransferase; Glutamyl Aminopeptidase; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Immunoglobulin G; Immunoglobulin M; Lamivudine; Lymphoma, Non-Hodgkin; Male; Middle Aged; Virus Activation

2004
Hepatitis B virus reactivation in a case of non-Hodgkin's lymphoma treated with chemotherapy and rituximab: necessity of prophylaxis for hepatitis B virus reactivation in rituximab therapy.
    Leukemia & lymphoma, 2004, Volume: 45, Issue:3

    Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Female; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Liver Failure; Lymphoma, Non-Hodgkin; Rituximab; Serologic Tests; Virus Activation

2004
Adefovir dipivoxil to prevent exacerbation of lamivudine-resistant hepatitis B infection during chemotherapy for non-Hodgkin's lymphoma.
    The American journal of gastroenterology, 2004, Volume: 99, Issue:8

    Topics: Adenine; Adult; Antiviral Agents; Carrier State; Drug Resistance; Female; Hepatitis B; Humans; Lamivudine; Lymphoma, Non-Hodgkin; Organophosphonates; Reverse Transcriptase Inhibitors

2004
Fatal fulminant hepatitis B after withdrawal of prophylactic lamivudine in hematopoietic stem cell transplantation patients.
    International journal of hematology, 2005, Volume: 81, Issue:4

    Topics: Acute Disease; Adult; Anti-HIV Agents; Fatal Outcome; Female; Hematopoietic Stem Cell Transplantation; Hepatitis B; Humans; Lamivudine; Leukemia, Myeloid; Liver Failure, Acute; Lymphoma, Non-Hodgkin; Male

2005
[Hepatitis B virus reactivation after cessation of prophylaxis with lamivudine in a patient with non-Hodgkins lymphoma treated with chemotherapy and rituximab].
    Medicina clinica, 2006, Jun-03, Volume: 127, Issue:1

    Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Female; Hepatitis B; Hepatitis B Antigens; Humans; Lamivudine; Lymphoma, Non-Hodgkin; Middle Aged; Recurrence; Reverse Transcriptase Inhibitors; Rituximab; Virus Activation

2006
Long-term outcome after prophylactic lamivudine treatment on hepatitis B virus reactivation in non-Hodgkin's lymphoma.
    Yonsei medical journal, 2007, Feb-28, Volume: 48, Issue:1

    Topics: Adult; Aged; Drug Administration Schedule; Female; Hepatitis B; Hepatitis B Antibodies; Hepatitis B virus; Humans; Lamivudine; Liver; Lymphoma, Non-Hodgkin; Male; Middle Aged; Reverse Transcriptase Inhibitors; Survival Analysis; Treatment Outcome; Virus Activation

2007
Reactivation of lamivudine-resistant occult hepatitis B in an HIV-infected patient undergoing cytotoxic chemotherapy.
    Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 2007, Volume: 39, Issue:1

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Drug Resistance, Viral; Hepatitis B; Hepatitis B virus; HIV; HIV Infections; Humans; Lamivudine; Lymphoma, Non-Hodgkin; Male; Virus Activation

2007
The relationship of hepatitis B virus infection and non-Hodgkin's lymphoma and its impact on clinical characteristics and prognosis.
    European journal of haematology, 2007, Volume: 79, Issue:2

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anthracyclines; Drug Therapy, Combination; Female; Hepatitis B; Humans; Lamivudine; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prevalence; Prognosis; Steroids; Survival Rate

2007
Successful treatment with lamivudine for fulminant reactivated hepatitis B infection following intensive therapy for high-grade non-Hodgkin's lymphoma.
    Annals of oncology : official journal of the European Society for Medical Oncology, 1998, Volume: 9, Issue:4

    Topics: Adult; Anti-HIV Agents; Antineoplastic Combined Chemotherapy Protocols; Carrier State; Fatal Outcome; Hepatitis B; Humans; Lamivudine; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Male; Recurrence

1998
Lamivudine allows completion of chemotherapy in lymphoma patients with hepatitis B reactivation.
    British journal of haematology, 2000, Volume: 108, Issue:2

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Hepatitis B; Humans; Lamivudine; Lymphoma, Non-Hodgkin; Male; Middle Aged; Reverse Transcriptase Inhibitors; Virus Activation

2000
A possible role for lamivudine as prophylaxis against hepatitis B reactivation in carriers of hepatitis B who undergo chemotherapy and autologous peripheral blood stem cell transplantation for non-Hodgkin's lymphoma.
    Bone marrow transplantation, 2001, Volume: 27, Issue:4

    Topics: Adult; Antineoplastic Agents; DNA, Viral; Drug Therapy, Combination; Hematopoietic Stem Cell Transplantation; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Lymphoma, Non-Hodgkin; Male; Reverse Transcriptase Inhibitors; Transplantation, Autologous; Virus Activation

2001
Lamivudine and glycyrrhizin for treatment of chemotherapy-induced hepatitis B virus (HBV) hepatitis in a chronic HBV carrier with non-Hodgkin lymphoma.
    Leukemia & lymphoma, 2001, Volume: 41, Issue:1-2

    Topics: Anti-HIV Agents; Antineoplastic Agents; Chronic Disease; DNA, Viral; Drug Therapy, Combination; Glycyrrhizic Acid; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Lymphoma, Non-Hodgkin; Male; Middle Aged; Reverse Transcriptase Inhibitors; Testicular Neoplasms; Virus Activation

2001
Clinical progress and transmission perils stressed at second human retroviruses conference.
    Journal of the International Association of Physicians in AIDS Care, 1995, Volume: 1, Issue:2

    Topics: Acyclovir; AIDS Vaccines; AIDS-Related Opportunistic Infections; Antineoplastic Agents; Antiviral Agents; CD4 Lymphocyte Count; Cytomegalovirus Retinitis; Herpesviridae; HIV Infections; Humans; Interleukin-2; Lamivudine; Lymphoma, Non-Hodgkin; Retroviridae; Sarcoma, Kaposi; Zalcitabine; Zidovudine

1995
Primary prophylaxis with lamivudine of hepatitis B virus reactivation in chronic HbsAg carriers with lymphoid malignancies treated with chemotherapy.
    British journal of haematology, 2001, Volume: 115, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Cyclophosphamide; Cytarabine; Doxorubicin; Female; Granulocyte Colony-Stimulating Factor; Hematologic Neoplasms; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Hodgkin Disease; Humans; Lamivudine; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myeloid; Lymphoma, Non-Hodgkin; Male; Middle Aged; Multiple Myeloma; Pilot Projects; Prednisone; Vidarabine; Vincristine; Virus Activation

2001
Prophylaxis of hepatitis B reactivation using lamivudine in a patient receiving rituximab.
    American journal of hematology, 2001, Volume: 68, Issue:4

    Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Lymphoma, Non-Hodgkin; Male; Middle Aged; Reverse Transcriptase Inhibitors; Rituximab; Treatment Outcome; Virus Activation

2001
Efficacy of lamivudine to prevent hepatitis reactivation in hepatitis B virus-infected patients treated for non-Hodgkin lymphoma.
    Blood, 2002, Jan-15, Volume: 99, Issue:2

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Comorbidity; Drug Evaluation; Female; Hepacivirus; Hepatitis B virus; Hepatitis B, Chronic; Hepatitis C; Humans; Immunocompromised Host; Lamivudine; Liver Function Tests; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prevalence; Reverse Transcriptase Inhibitors; Treatment Outcome; Virus Activation; Virus Replication

2002
Successful treatment with lamivudine for reactivated hepatitis B infection following chemotherapy for non-Hodgkin's lymphoma.
    Annals of hematology, 2002, Volume: 81, Issue:1

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Hepatitis B, Chronic; Humans; Lamivudine; Lymphoma, Non-Hodgkin; Male; Recurrence; Reverse Transcriptase Inhibitors

2002
Lamivudine for the treatment of hepatitis B virus reactivation following chemotherapy for non-Hodgkin's lymphoma.
    British journal of haematology, 2002, Volume: 116, Issue:1

    Topics: Acute Disease; Adult; Aged; Antiviral Agents; Female; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prospective Studies; Recurrence; Virus Activation

2002
Successful long-term control with lamivudine against reactivated hepatitis B infection following intensive chemotherapy and autologous peripheral blood stem cell transplantation in non-Hodgkin's lymphoma: experience of 2 cases.
    American journal of hematology, 2002, Volume: 70, Issue:1

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carrier State; Hematopoietic Stem Cell Transplantation; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Lymphoma, Non-Hodgkin; Male; Middle Aged; Reverse Transcriptase Inhibitors; Secondary Prevention; Time Factors; Virus Activation

2002
[Lamivudine for the prevention of chronic hepatitis B exacerbations during chemotherapy for non-Hodgkin's lymphoma].
    Nederlands tijdschrift voor geneeskunde, 2002, Jun-15, Volume: 146, Issue:24

    Topics: Acute Disease; Adolescent; Antineoplastic Agents; Fatal Outcome; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Lymphoma, Non-Hodgkin; Male; Middle Aged; Reverse Transcriptase Inhibitors; Virus Activation

2002